Drugs / nicotine acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00996034 | Sep 2009 → Feb 2011 | nicotine dependence | Yale University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00659321 Comparator | Jan 2007 → Sep 2008 | hyperlipidemia, metabolic syndrome X | GWT-TUD GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nicotine acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00659321 ↗ |
| Known as | Nicotine bitartrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00996034 ↗ |
| Route | Intravenous | “0.5-1.5 mg of Nicotine bitartrate, I.V. on each of two SPECT Scan days” NCT00996034 ↗ |